Finasteride Before and After: Clinical Trial Data

Medically reviewed by [Reviewer Name, MD] | Last reviewed: August 2026 | Editorial policy

This page presents clinical trial before-and-after data for finasteride, objective, measured outcomes from randomized controlled trials, not individual case photos. User-shared photos vary enormously based on lighting, angle, and selection bias and are not a reliable guide to expected results.

Hair Count: Before vs. After in Key Trials

TrialDurationChange (Fin 1 mg)Change (Placebo)Net Difference
Kaufman 1998 (vertex)12 monthsIncrease from baselineHair loss from baseline+107 hairs in a 1-inch circle (5.1 cm²)
Rossi 2011 (10-year)10 yearsEfficacy not reduced over time; 42.8% of men aged 20 to 30 did not improveN/A (no placebo at 10yr)N/A

Investigator-Rated Global Photographic Assessment

In the key trials, trained investigators assessed standardized scalp photographs at baseline and 12 months, blinded to treatment:

Rating at 12 monthsFinasteride 1 mgPlacebo
Greatly increased14%1%
Moderately increased34%6%
Slightly increased23%14%
No change12%7%
Slightly decreased11%22%
Moderately decreased5%31%
Greatly decreased1%19%

The key finding: 86% of finasteride users showed no further hair loss at 12 months vs. 42% on placebo. 48% showed visible improvement vs. 7% on placebo.

What Clinical “Before and After” Actually Looks Like

Clinical photographs used in trials are standardized: consistent lighting (typically cross-polarized), identical camera distance, same scalp position marked by reference points. Under these conditions, a +7 hairs/cm² change in a 1-inch circle corresponds to roughly 50-70 additional hairs visible in the target area, a change that is detectable by trained investigators but may or may not be noticeable to patients in daily life without standardized photography.

See also: Full results timeline | Shedding phase | What to expect at 1 year | 1998 trial data

Sources

  • Kaufman KD, et al. “Finasteride in the treatment of men with androgenetic alopecia.” J Am Acad Dermatol. 1998;39(4):578-589.
  • Rossi A, et al. “Finasteride, 1 mg daily administration on male androgenetic alopecia in different age groups: 10-year follow-up.” Dermatol Ther. 2011;24(4):455-461.